Bialzepam Retard

Quick links

Choose a section

Quick links to important sections

Advertisements

Bialzepam Retard

Selected form

Advertisements

Overview of Bialzepam Retard

Quick Facts

Property Description
Active ingredient Diazepam
Form Prolonged-release capsule ("Retard")
Pharmacological class Benzodiazepine, CNS Depressant
General purpose Calming the nervous system, easing muscle tension
Origin Synthetic compound

Identity and Classification

Bialzepam Retard is a synthetic compound containing the active ingredient Diazepam, a substance derived from the 1,4-benzodiazepine core structure. It belongs to the benzodiazepine class of medicines and is formally categorized as a Central Nervous System (CNS) depressant. This pharmacological classification signifies its primary function is to reduce activity within the brain and spinal cord. Diazepam is utilized for its action across anxiety, muscle spasm, and seizure-related conditions. The drug's known metabolite, N-desmethyldiazepam, contributes to its long duration of action.


The Role of the Prolonged-Release Capsule (Retard Formulation)

The medicine is supplied as a prolonged-release capsule, intended for administration via the oral route. The designation "Retard" indicates that the formulation is a slow-release oral formulation engineered to release the Diazepam content gradually. This design is a key differentiating factor for Bialzepam Retard when compared to immediate-release versions of Diazepam. This process utilizes a specialized vehicle and pharmaceutical excipients to ensure the active compound is liberated and absorbed over an extended period, which is often preferred for scenarios requiring sustained, consistent symptom management.


General Purpose and Effect of Diazepam

The general purpose of this CNS depressant is rooted in its ability to modulate the effects of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid), leading to a broad reduction in neuronal excitability. The medication is utilized to provide calming relief from states of excessive emotional distress and anxiety, and to ease abnormally high tension or stiffness in the skeletal muscles. Its fundamental effect is stabilization and generalized soothing of the nervous system.

Regulatory References

  1. Diazepam: MedlinePlus Drug Information
Advertisements

What side effects are possible with Bialzepam Retard?

Possible side effects and safety information

The safety profile for Bialzepam Retard (Diazepam) is officially documented according to classifications established by regulatory bodies.

Adverse Reactions by Frequency

Adverse reactions are grouped by their expected rate of occurrence:

  • Very Common: Drowsiness (sedation).
  • Common: Fatigue, ataxia (impaired coordination), confusion, and tremor.
  • Uncommon: Concentration difficulties, headache, dizziness, slurred speech (dysarthria), and anterograde amnesia (inability to recall new information).
  • Rare: Paradoxical reactions (e.g., aggression, hostility), syncope (fainting), hypotension, bradycardia, jaundice, and urinary retention.

These effects are generally classified under Nervous System Disorders and Psychiatric Disorders in regulatory labeling, reflecting the drug's activity as a Central Nervous System depressant.

Serious Safety Considerations

Officially documented serious adverse reactions include profound sedation, respiratory depression, coma, and death, particularly when the medicine is used with opioids or other Central Nervous System depressants. Furthermore, rare cardiovascular events such as cardiac arrest and hypotension are documented.

Safety Patterns and Restrictions

The risk of developing physical and psychological dependence is associated with the duration of exposure. Abrupt cessation may lead to withdrawal symptoms or a rebound phenomenon where the original symptoms return in an enhanced form. The medicine is formally contraindicated (should not be used) in patients with conditions such as severe hepatic insufficiency, Myasthenia gravis, and sleep apnea syndrome. Older adults are officially noted to be more susceptible to CNS effects, increasing the risk of falls.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

The overdose profile for Bialzepam Retard (Diazepam) is defined by its effects on the Central Nervous System and Respiratory System, as documented in regulatory materials.

Documented Overdose Manifestations

Domain Regulatory Statement
Documented Presentations Overdose symptoms include Drowsiness, Confusion, Lethargy, Uncoordinated Movement (Ataxia), Slurred Speech, and Diminished Reflexes. These signs of CNS depression may progress to a Stuporous State or Coma.
Physiological Systems Affected The overdose primarily affects the Central Nervous System and the Respiratory system, potentially leading to Hypotension (low blood pressure).
Exposure-Related Factors The risk of profound sedation, respiratory depression, coma, and death is significantly increased by concomitant use with Opioids, Alcohol, or other CNS depressants.
Population-Specific Notes Elderly patients are at an increased risk of severe outcomes, including apnea or cardiac arrest.

Required Emergency Action

Seek medical help right away. Regulatory guidance mandates immediately calling Emergency Services if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened (unresponsive). Immediate medical care is required for symptoms including unusual dizziness, extreme sleepiness, or slowed breathing.

Supportive Management and Antidote

The regulatory profile mandates Supportive Care as the mainstay of treatment, including Airway Management, Mechanical Ventilation for severe respiratory compromise, and close Monitoring of Vital Signs. The antagonist Flumazenil is available but is generally not recommended for routine reversal in acute toxicity due to the documented risk of precipitating seizures or other adverse events, as noted in official prescribing information.


The regulatory profile for Bialzepam Retard overdose is defined by the high risk of CNS depression that can progress to life-threatening respiratory depression and coma. The official documents mandate immediate emergency contact when severe symptoms, such as the inability to be aroused or difficulty breathing, are observed. Management protocols emphasize supportive care and close vital sign monitoring, while noting the restricted and cautioned use of the available antagonist.

Advertisements

Therapeutic Uses of Bialzepam Retard

What Bialzepam Retard Treats: Main Uses and Benefits


Easing Periods of Heightened Symptomatic Distress

Bialzepam Retard is commonly used to help manage symptoms related to acute or episodic changes that create noticeable interference with daily stability. This formulation is indicated for use in conditions presenting with acute episodes. The primary therapeutic domain is applied across areas where additional symptomatic support is needed. Its core use is offering short-term, symptomatic assistance to help patients manage overwhelming discomfort.


Supportive Relief for Fluctuating Symptom Patterns

This medication is applied across condition categories characterized by episodic or fluctuating symptom patterns, particularly those involving increased physiological or emotional tension. It is relevant in clinical settings where supportive symptom management is appropriate and contributes to easing the overall symptom load. It offers symptomatic relief that helps patients cope more steadily.


Quick Facts

  • Therapeutic Focus: Relevant for Symptoms that Interfere with Daily Functioning.
  • Primary Use: Commonly used across conditions presenting with acute episodes.
  • Patient Benefit: Supports general well-being during symptomatic phases.
Advertisements

Eligibility and Restrictions for Use

Eligibility and Contraindications

The eligibility for Bialzepam Retard is defined by official regulatory labeling, outlining specific populations and conditions where use is prohibited or restricted. The medicine is generally approved for use in the general adult population.

Absolute Contraindications (Must Not Use):

  • Known hypersensitivity to Diazepam or other benzodiazepines.
  • Myasthenia Gravis, Severe Respiratory Insufficiency, Sleep Apnea Syndrome.
  • Severe Hepatic Insufficiency or Acute Narrow-Angle Glaucoma.

Age and Condition Restrictions:

  • Pediatric Use: The medicine is contraindicated in children under 6 months of age due to a lack of established clinical experience.
  • Older Adults (Geriatric): Use requires special caution and a lower starting dose due to slower drug clearance and increased risk of CNS effects, such as falls.
  • Physiological Impairment: Patients with chronic respiratory, mild-to-moderate hepatic, or renal impairment are typically limited to restricted use and require careful medical monitoring.
  • Pregnancy and Lactation: Use is not recommended during pregnancy or breastfeeding, as the drug and its metabolites are excreted into breast milk and carry a potential risk to the newborn.
Advertisements

What should I know about interactions with other medicines?

The active ingredient in Bialzepam Retard has a documented interaction profile governed by both pharmacodynamic and pharmacokinetic mechanisms. The regulatory classification highlights a high severity warning for co-administration with opioid analgesics due to the officially classified additive CNS depressant effect, which carries a documented risk of profound sedation and respiratory depression. Similarly, simultaneous ingestion of alcohol or other CNS depressants, including sedating antidepressants, antipsychotics, and muscle relaxants, is restricted due to this enhanced depressive effect.

Pharmacokinetic interactions are centered on the metabolism of the active substance by hepatic CYP3A4 and CYP2C19 enzymes. Inhibitors of these enzymes (e.g., cimetidine, fluoxetine, or specific antifungals) are documented to decrease the elimination rate, which may increase drug exposure. Conversely, enzyme inducers (e.g., rifampicin or certain anticonvulsants) are recorded to increase clearance, potentially reducing plasma concentration. Officially recorded non-medicinal interactions include restrictions on grapefruit products and certain herbal products due to their potential to alter concentration or enhance sedation. A population-specific constraint notes that the elderly may experience accumulation and heightened interaction effects due to a documented reduction in clearance.

Advertisements

Mechanism of Action

Bialzepam Retard, containing diazepam, exerts its effect within the central nervous system (CNS) by targeting the GABA A receptor complex. It functions as a positive allosteric modulator at the interface between the alpha and gamma subunits of the GABA A receptor, primarily those containing alpha1, alpha2, alpha3, and alpha5 subunits.

The binding of diazepam to this specific site does not directly activate the receptor but induces a conformational change that enhances the affinity of the receptor for the endogenous neurotransmitter gamma-aminobutyric acid (GABA). This allosteric modification results in an increased frequency of chloride channel opening when GABA is bound. The resultant influx of negatively charged chloride ions ( Cl^-) across the neuronal membrane causes hyperpolarization of the post-synaptic neuron. This intracellular consequence reduces neuronal excitability, leading to a general downstream cascade of reduced signal propagation throughout the affected CNS circuits. This modulation translates to a system-level decrease in overall neural activity.

Advertisements

Dosage and Administration Information

How to Use Bialzepam Retard

This section outlines the general principles for the administration and use of Bialzepam Retard (Diazepam prolonged-release capsule), focusing strictly on procedural instruction and high-level use patterns.


Official Administration Protocol

Feature Guideline
Route of Administration The medicine is intended for oral use only.
Dosing Schedule The standard adult daily dose is typically 10 mg to 20 mg, administered as one 10 mg capsule once daily or in divided doses every 12 hours.
Dose Initiation Principle Treatment must always be initiated with the lowest effective dose.
Intake Method The prolonged-release capsule must be swallowed whole to maintain its slow-release properties.
Administration Constraint The capsule must not be crushed or broken.

Duration and Specific Use Contexts

The use of this medication is designated for short-term administration. The duration of treatment should be kept as brief as possible, generally not exceeding four weeks, a period which includes the necessary time for gradual dose reduction. Treatment must be tapered off slowly upon discontinuation, as sudden cessation is avoided in the usage protocol.

For specific populations, particular caution regarding dosage is required. In older adults (the elderly) and individuals with hepatic or renal impairment, the dose is limited to the minimum effective dose and increased with care to avoid accumulation. If a dose is missed, it should not be taken if more than one hour has elapsed since the scheduled time, and a double dose must never be taken. The prolonged-release form is not generally intended for use in children.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Chronic Pain Management

Studies have explored whether the drug has a role in managing chronic back pain. Research in this area has focused on the drug's short-term and longer-term use.

One key study evaluated whether the drug was associated with a sustained change in pain scores over a 12-week period. The primary endpoint measured was the difference in the reported pain intensity from the start to the end of the study. This research examined whether the drug was associated with a reduction in pain and improvement in physical function.

The findings reported on the observed data regarding tolerability and the time until changes in pain intensity were observed.


Dosage and Administration

Research has also concentrated on the optimal use of the drug. Studies looked at different dosage amounts and their relationship to observed outcomes.

  • Low Dose vs. High Dose: Trials assessed whether a higher initial dose was associated with a greater change in pain intensity compared to a lower maintenance dose.
  • Administration with Food: Furthermore, the study reported findings related to whether the drug was administered with food. This sub-analysis examined whether administration alongside a meal had an impact on the drug's overall profile.

Specific Populations

Elderly Patients

The study evaluated the drug in the context of pain management in the elderly. This research population was defined as individuals over the age of 65. The focus was on monitoring potential changes in the tolerability compared to younger populations.

Combination Therapy

A combination therapy trial compared the drug to other standard treatments. Researchers assessed whether using the drug alongside an existing therapy was associated with different outcomes than the existing therapy alone.

Individuals with Comorbidities

Researchers monitored how the drug's metabolic profile might differ in participants with reduced kidney function. Evidence remains limited regarding the use of this drug in patients with severe heart conditions. It is not yet clear whether the drug's effect differs in this population.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bialzepam Retard (FAQ)


Q: How long does the effect of Bialzepam Retard typically last?

A: The active substance in Bialzepam Retard is classified as long-acting. Official pharmacokinetic data indicates that the drug's effects can last longer than 12 hours. This duration is attributed to the prolonged-release formulation and the long half-life of the active substance and its primary metabolite.


Q: Are there known effects of taking Bialzepam Retard long-term?

A: Regulatory warnings state that using the medication over a prolonged period can lead to the development of tolerance and physical and psychological dependence. The risk of these effects, which include withdrawal symptoms upon stopping, increases with the length of time the drug is used.


Q: Is Bialzepam Retard a medication that is difficult to stop taking?

A: Official warnings note that the medication may cause physical dependence, even when used as prescribed. Because of this, stopping the drug abruptly, especially after prolonged use, is associated with a risk of serious withdrawal reactions or a return of the original symptoms in an enhanced form (rebound phenomenon).


Q: Is it possible to take Bialzepam Retard during pregnancy?

A: Official guidance indicates that use during pregnancy is not recommended. Regulatory documents state that taking the active substance late in pregnancy carries a risk of potential effects for the newborn, including withdrawal symptoms.


Q: Can Bialzepam Retard be used while breastfeeding?

A: Regulatory information advises against using this medication while breastfeeding. This is because the active substance and its metabolites are known to pass into breast milk, which carries a potential risk to the newborn.


Q: Do many people experience changes in appetite while on Bialzepam Retard?

A: Changes in appetite are officially documented as a possible effect of the active substance. However, according to regulatory data, this side effect is generally considered rare in occurrence.


Q: What does the research say about the effectiveness of Bialzepam Retard?

A: The active substance is officially indicated for the management of anxiety disorders and for the short-term relief of anxiety symptoms. Official product information also supports its use as an adjunct treatment for muscle spasms and certain seizure disorders.


Q: Does the official information mention any connection between Bialzepam Retard and memory problems?

A: Yes, official safety documentation lists anterograde amnesia as an uncommon adverse reaction associated with the active substance. Anterograde amnesia is described as an inability to recall new information that occurs after the medication has been taken.


Q: Can individuals with a history of substance use disorders take Bialzepam Retard?

A: Official product information states that the medication should be used with extreme caution in patients who have a history of alcohol or drug abuse. This caution is due to the increased risk of abuse, misuse, and dependence associated with the drug.


Q: Does Bialzepam Retard work immediately after taking it?

A: While the active substance starts to be absorbed quickly after taking an oral formulation, the time to reach peak concentrations in the body is generally reported to be within the range of one to one and a half hours. The speed of onset can vary by individual.


Q: What kind of side effects are considered rare for Bialzepam Retard?

A: Rare side effects documented in official regulatory labeling include the emergence of paradoxical reactions, such as aggression or hostility. Other rare effects documented include jaundice, changes in heart rate (bradycardia), and low blood pressure (hypotension).


Q: Can Bialzepam Retard be taken by elderly patients?

A: Yes, the medication can be taken by older adults, but regulatory guidance requires special caution. Official labeling advises that treatment should begin with a reduced dose, as these patients may be more sensitive to the drug's effects, increasing the risk of adverse reactions like oversedation and falls.


Q: What happens if someone misses a dose of Bialzepam Retard?

A: If a regular dose is missed, patients should consult the specific administration instructions provided with the medicine. Official protocol strictly advises that a double dose must never be taken to make up for a missed dose.


Q: Are there any foods or drinks that interact with Bialzepam Retard?

A: Official information warns that consuming alcohol is restricted while taking the medication due to an increased risk of severe sedation. Furthermore, certain substances like grapefruit and grapefruit juice may interact with the active substance and can increase the risk of side effects.


Q: Is Bialzepam Retard used for anxiety disorders?

A: Yes, regulatory documents indicate that the active substance is approved for the management of anxiety disorders and for the short-term relief of the symptoms of anxiety.


Q: What types of mental health conditions is Bialzepam Retard commonly used to manage?

A: The active substance is officially indicated for the management of anxiety disorders. It is also used in a supporting role for managing muscle spasms and acute agitation related to alcohol withdrawal.


Q: Is it possible for Bialzepam Retard to cause vivid dreams or nightmares?

A: Official documentation reports that sleep disturbances, including nightmares and vivid dreams, can occur. These effects are sometimes noted as a potential symptom of withdrawal or rebound effects when the drug is stopped.


Q: Does Bialzepam Retard affect blood pressure?

A: Yes, official adverse reactions lists for the active substance include hypotension (low blood pressure) as a potential side effect that has been reported.


Q: Do you need a special prescription for Bialzepam Retard?

A: Yes, the active substance is officially classified as a Schedule IV controlled substance. Because of this legal designation, prescriptions for the drug are subject to specific government regulations regarding their issuance, security, and dispensing.


Q: Does the time of day matter when taking Bialzepam Retard?

A: The prolonged-release formulation is typically prescribed for once-daily use, though a patient's regimen may involve divided doses. The specific time of day is part of the prescribed schedule, which aims to provide sustained symptom relief.


Q: Is Bialzepam Retard used to help with sleep issues?

A: While the active ingredient is not directly indicated only for insomnia, its approved use for anxiety disorders can address related symptoms. Difficulty sleeping is a common symptom of anxiety.


Q: Are allergic reactions common with Bialzepam Retard?

A: The drug is formally contraindicated in anyone with a known hypersensitivity to the active substance or other medicines in the same class. Although rare, serious allergic reactions, which may involve swelling of the face, are officially documented.


Q: Do people typically feel 'high' or euphoric on Bialzepam Retard?

A: Euphoria is officially documented as one of the adverse reactions that has occurred with the abuse and/or misuse of the active substance. This is a documented potential outcome associated with the abuse and/or misuse of the active substance.


Q: Is Bialzepam Retard covered by most health insurance plans?

A: The generic version of the active substance is widely available and typically covered by most health insurance plans, including government programs. The specific coverage details depend on the patient's individual plan, pharmacy, and the specific brand or formulation prescribed.


Q: What should a patient do if they accidentally take two doses close together?

A: Regulatory guidance for missed doses strictly advises against taking a double dose. If more than the prescribed amount is taken or if doses are taken too close together, regulatory guidance indicates that medical advice should be sought promptly.


Q: Is the medication considered a controlled substance in some regions?

A: Yes, the active substance is officially classified as a Schedule IV controlled substance in several major countries, including the United States. This classification indicates a potential for abuse and dependence, which necessitates specific governmental regulatory controls.


Q: Does the way I eat affect how Bialzepam Retard is absorbed?

A: Official pharmacokinetic information indicates that taking the active substance with a meal can delay and decrease its absorption. This means it may take longer for the drug to reach its maximum concentration in the body.


Q: Is it normal to feel a bit 'foggy' when starting Bialzepam Retard?

A: The official documentation lists drowsiness, fatigue, and confusion as 'Very Common' or 'Common' side effects. These effects are often most noticeable when starting treatment due to the drug's central nervous system depressant activity.


Q: Does Bialzepam Retard lose its effectiveness over time?

A: Official product information notes that some loss of response to the effects of the active substance may develop after repeated use of the drug for a prolonged time. This phenomenon is scientifically referred to as tolerance.

Advertisements

How should Bialzepam Retard be stored and disposed of?

The storage and disposal of Bialzepam Retard (Diazepam prolonged-release capsules) are governed by official regulatory mandates to ensure stability and public safety. The medicine must be stored at controlled room temperature (20 C to 25 C) and kept from freezing. Protection from heat, moisture, and direct light is required, necessitating storage in a closed container.

As a Schedule IV controlled substance, it must be stored in a safe, secure place and kept out of the sight and reach of children. Unused or expired capsules should be disposed of promptly via an official drug take-back location. If a take-back program is unavailable, follow FDA guidelines for mixing the medicine with an undesirable substance before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bialzepam Retard found in:

A-Z Index: